Dash (Discovery Tools (Healthcare))

dash.bio · San Francisco, United States of America

Dash is a healthcare technology company that provides a discovery platform and tools for analyzing and integrating biomedical and multi-omics data, enabling researchers and life sciences organizations to accelerate target discovery and translational research. Its software aggregates and structures complex biological datasets to support data-driven decision making in drug discovery and precision medicine programs. The company generates revenue through subscriptions and enterprise licenses to its data and analytics platform and related services.

  • Data Integration & ETL
  • Business Intelligence & Dashboards
Revenue
$3.0M
Employees
20
Founded
2020
Headquarters
San Francisco, United States of America

What 7 Arbolus experts think of Dash (Discovery Tools (Healthcare))

NPS distribution is positive overall: 29% gave a score of 9 or above, 43% gave a score of 7-8, and 14% recorded a 6. Renewal intent is fully positive among the highest spenders, neutral among low spenders (Not Sure), and unreported elsewhere. Stickiness favors newer () and established (>1 year) deployments, with renewals confirmed for major clients. NPS and renewal intent are notably highest among procurement and executive-level influencers. Customers with longer usage display continued advocacy, suggesting strong product stickiness.Overall Customer Sentiment: Positive

Who reviewed Dash (Discovery Tools (Healthcare))

Total customers 7 6 current · 1 former
Reviews growth +7 in six months
Seniority of respondents
  • C-Suite 71% (5)
  • Manager 29% (2)
Strategy Partner Manager NPS 7
Operations Leader C-Suite NPS 8 Will renew
Operations Leader C-Suite NPS 6 Undecided

Employer names and spend open once the report publishes.

Tell us when the Dash (Discovery Tools (Healthcare)) report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

14 Net Promoter Score, from 7 scored reviews
  • Promoters 2
  • Passives 4
  • Detractors 1

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 67%
  • Will renew 2
  • Undecided 1
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 67% 3 answers
  • 8.5/10 Average score from customers who will renew
  • 6/10 Average score from undecided customers

For people who use Dash (Discovery Tools (Healthcare))

Do you use Dash (Discovery Tools (Healthcare)) at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 7 customers of Dash (Discovery Tools (Healthcare)) have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.